You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adult (>18 years) at very high risk of relapse

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)

Not yet recruiting
  • ACUTE LYMPHOBLASTIC LEUKEMIA
  • (no location specified)
Feb 17, 2023

RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (RSVpreF 120 µg, RSVpreF 60 µg, )

Not yet recruiting
  • RESPIRATORY SYNCYTIAL VIRUS (RSV)
  • RSVpreF 120 µg
  • +2 more
  • (no location specified)
Jun 2, 2023

Respiratory Syncytial Virus Trial in Panama, United States (mRNA-1345, Placebo)

Not yet recruiting
  • Respiratory Syncytial Virus
  • mRNA-1345
  • Placebo
  • Banning, California
  • +20 more
Oct 18, 2023

Propionic/Methylmalonic Acidemias, Maple Syrup Urine Disease, Citrullinemia Trial in Aktobe (Obtaining Dry Blood Spots From

Recruiting
  • Propionic/Methylmalonic Acidemias
  • +28 more
  • Obtaining Dry Blood Spots From Healthy Newborns (Aged 1-7 Days)
  • +5 more
  • Aktobe, Aktobe Region, Kazakhstan
    Regional perinatal center of Aktobe region
Jun 8, 2023

Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

Completed
Has Results
  • Adult Acute Myeloid Leukemia in Remission
  • Recurrent Adult Acute Myeloid Leukemia
  • Aurora, Colorado
  • +1 more
Dec 30, 2021

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL, Infants With Very High Risk KMT2A B-ALL, Patients With CNS

Active, not recruiting
  • Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL
  • +2 more
  • Murine CART19
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jan 11, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Blasts Under

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 10, 2022

Respiratory Syncytial Virus Infection Prevention Trial in Worldwide (Ad26.RSV.preF-based Vaccine, Placebo)

Completed
  • Respiratory Syncytial Virus Infection Prevention
  • Ad26.RSV.preF-based Vaccine
  • Placebo
  • Coral Gables, Florida
  • +22 more
Sep 27, 2022

Gastrointestinal Tolerance Trial in Newquay, Penzance (Experimental Nutritional Pudding)

Completed
  • Gastrointestinal Tolerance
  • Experimental Nutritional Pudding
  • Newquay, Cornwall, United Kingdom
  • +2 more
Jan 12, 2022

Gastro-Intestinal Tolerance Trial in Newquay, Penzance, Poole (High Protein, Energy Dense Nutritional Supplement)

Completed
  • Gastro-Intestinal Tolerance
  • High Protein, Energy Dense Nutritional Supplement
  • Newquay, Cornwall, United Kingdom
  • +2 more
Jun 10, 2021

SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination

Active, not recruiting
  • SARS-CoV Infection
  • Covid19
  • SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
  • +5 more
  • Birmingham, Alabama
  • +155 more
Dec 16, 2022

MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +46 more
Jan 20, 2023

Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Brasschaat, Belgium
  • +9 more
Jan 19, 2023

Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Malignant Hematological Diseases
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Jul 3, 2023

Acute Lymphoid Leukemia Trial in Philadelphia (huCART19)

Recruiting
  • Acute Lymphoid Leukemia
  • huCART19
  • Philadelphia, Pennsylvania
    Children's Hospital of Pennsylvania
Jul 21, 2022

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • (no location specified)
Nov 15, 2023

Cardiotoxicity, HER2-positive Breast Cancer, Heart Failure Trial in London (Phased withdrawal of heart failure medications)

Not yet recruiting
  • Cardiotoxicity
  • +3 more
  • Phased withdrawal of heart failure medications
  • London, United Kingdom
  • +1 more
May 19, 2023

Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Stem Cell Transplantation
  • Tel Aviv, Israel
  • +2 more
Jan 23, 2023

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant

Recruiting
  • ER+ Breast Cancer
  • HER2-negative Breast Cancer
  • Palbociclib 125Mg Tab
  • +5 more
  • Christchurch, United Kingdom
  • +3 more
May 19, 2022

Breast Cancer Trial in Limoges, Villejuif (Anti-aromatase inhibitor)

Not yet recruiting
  • Breast Cancer
  • Anti-aromatase inhibitor
  • Limoges, France
  • +1 more
Jul 25, 2022

Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))

Recruiting
  • Acute Myeloid Leukemia
  • A arm (DA-90)
  • +3 more
  • New York, New York
  • +9 more
Sep 30, 2021

Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

Recruiting
  • Leukemia, Myeloid, Acute
  • Minimal Residual Disease
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital (NCCH)
    Feb 2, 2023

    PET-CT Imaging in Relapsed/Refractory Acute Leukemias

    Not yet recruiting
    • B Cell
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 4, 2023

      OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain

      Recruiting
      • Non-small Cell Lung Cancer
        • Santiago de Compostela, Galicia, Spain
          Luis Ángel Leon Mateos
        Oct 3, 2023